Skinvisible SKVI
OTC SKVI
$0.18 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Skinvisible (SKVI) Price to Earnings (2018)

Updated

Skinvisible's Price to Earnings was 12.81 in Q4 2018, down 98.5% from the prior quarter.

Analysis

Skinvisible (SKVI) Price to Earnings (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Skinvisible 972,691.78 963,669.78 5,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 12.81
Sep 30, 2018 864.89
API Access

Skinvisible Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=SKVI&period=max&api_key=YOUR_API_KEY